Phase 1 data evaluating VRB-101, Verdiva Bio’s cAMP-biased oral GLP-1RA, provides proof of concept for potential once-weekly oral administration. Preclinical…
BENGALURU, India, June 19, 2025 /PRNewswire/ -- As part of its global Community Impact program focused on advancing digital inclusion…
June 19, 2025 01:00 ET | Source: Addex Therapeutics Strong cash position of CHF2.8 million at end of Q1 2025GABAB…
June 18, 2025 01:00 ET | Source: Addex Therapeutics Geneva, Switzerland, June 18, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a…
BERLIN, June 17, 2025 /PRNewswire/ -- Tongji Day and Tongji-German Symposium 2025 was successfully held in Berlin on June 13,…
SAN FRANCISCO and LONDON, June 17, 2025 /PRNewswire/ -- Owl Ventures, the world's largest venture capital firm focused on education…
June 13, 2025 16:01 ET | Source: Nurix Therapeutics, Inc. SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics,…
June 13, 2025 09:00 ET | Source: RAPT Therapeutics, Inc. SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) --…
SAN FRANCISCO, CALIFORNIA, June 13, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology…
Vancouver, Canada, June 12, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic…